BRPI0714761B8 - formulações compreendendo compostos cíclicos - Google Patents
formulações compreendendo compostos cíclicosInfo
- Publication number
- BRPI0714761B8 BRPI0714761B8 BRPI0714761A BRPI0714761A BRPI0714761B8 BR PI0714761 B8 BRPI0714761 B8 BR PI0714761B8 BR PI0714761 A BRPI0714761 A BR PI0714761A BR PI0714761 A BRPI0714761 A BR PI0714761A BR PI0714761 B8 BRPI0714761 B8 BR PI0714761B8
- Authority
- BR
- Brazil
- Prior art keywords
- independently
- protonated
- active agent
- cyclic
- dil
- Prior art date
Links
- 150000001923 cyclic compounds Chemical class 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 238000009472 formulation Methods 0.000 title abstract 2
- 239000013543 active substance Substances 0.000 abstract 3
- 125000003277 amino group Chemical group 0.000 abstract 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical group NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 abstract 1
- 239000003125 aqueous solvent Substances 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- -1 cyclic sugars Chemical class 0.000 abstract 1
- 125000000524 functional group Chemical group 0.000 abstract 1
- 150000002500 ions Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 235000000346 sugar Nutrition 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D323/00—Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nanotechnology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polyesters Or Polycarbonates (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06020286A EP1905454A1 (en) | 2006-09-27 | 2006-09-27 | Formulations comprising cyclic compounds |
| EP06020286.8 | 2006-09-27 | ||
| PCT/EP2007/008442 WO2008037484A2 (en) | 2006-09-27 | 2007-09-27 | Formulations comprising cyclic compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0714761A2 BRPI0714761A2 (pt) | 2013-07-02 |
| BRPI0714761B1 BRPI0714761B1 (pt) | 2021-03-23 |
| BRPI0714761B8 true BRPI0714761B8 (pt) | 2021-05-25 |
Family
ID=37728182
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0714761A BRPI0714761B8 (pt) | 2006-09-27 | 2007-09-27 | formulações compreendendo compostos cíclicos |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8513188B2 (enExample) |
| EP (2) | EP1905454A1 (enExample) |
| JP (1) | JP5335677B2 (enExample) |
| CN (2) | CN101557829A (enExample) |
| AU (1) | AU2007302270B2 (enExample) |
| BR (1) | BRPI0714761B8 (enExample) |
| CA (1) | CA2664568C (enExample) |
| ES (1) | ES2691736T3 (enExample) |
| IL (1) | IL197760A (enExample) |
| WO (1) | WO2008037484A2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2010323117B2 (en) | 2009-11-25 | 2015-09-03 | Capsugel Belgium Nv | Mucosal delivery compositions comprising a peptide complexed with a crown comppound and/or a counter ion |
| EP2332929A1 (en) * | 2009-11-25 | 2011-06-15 | ArisGen SA | Orthoester derivatives of crown ethers as carriers for pharmaceutical and diagnostic compositions |
| EP2526971A1 (en) * | 2011-05-25 | 2012-11-28 | ArisGen SA | Mucosal delivery of drugs |
| CN102863358B (zh) * | 2012-09-20 | 2014-02-12 | 华中农业大学 | 具有除草活性的化合物及其制备方法 |
| EP3000811B1 (en) * | 2014-09-24 | 2017-11-08 | Friedrich-Alexander-Universität Erlangen-Nürnberg | Crown Ether Complexes and Methods for Poducing the Same |
| US9937223B2 (en) | 2015-01-30 | 2018-04-10 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
| US9750785B2 (en) | 2015-01-30 | 2017-09-05 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
| US9687526B2 (en) | 2015-01-30 | 2017-06-27 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
| US9375478B1 (en) | 2015-01-30 | 2016-06-28 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
| US9925233B2 (en) | 2015-01-30 | 2018-03-27 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
| US9744209B2 (en) | 2015-01-30 | 2017-08-29 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
| CN108658264B (zh) * | 2018-04-17 | 2021-05-25 | 唐山师范学院 | 多支化聚环氧琥珀酸衍生物阻垢缓蚀剂的制备及其应用方法 |
| CN113527672B (zh) * | 2020-03-30 | 2022-09-20 | 复旦大学 | 一种胍基衍生物及其基因递释系统 |
| CN116178887B (zh) * | 2023-02-16 | 2024-10-29 | 东华大学 | 一种可降解快递袋材料及其制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2923787A1 (de) * | 1979-06-12 | 1980-12-18 | Max Planck Gesellschaft | Verfahren zur selektiven bildung von disulfidbruecken in polypeptiden und die dabei erhaltenen produkte als wirkstoffe enthaltende arzneimittel |
| US4474753A (en) * | 1983-05-16 | 1984-10-02 | Merck & Co., Inc. | Topical drug delivery system utilizing thermosetting gels |
| AU6738487A (en) * | 1985-12-04 | 1987-06-30 | Hsieh, D. | Transdermal delivery of drugs |
| US5023252A (en) * | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| EP2280004B1 (en) * | 1999-06-29 | 2016-04-20 | MannKind Corporation | Pharmaceutical formulations comprising insulin complexed with a diketopiperazine |
| CN1379771A (zh) * | 1999-09-20 | 2002-11-13 | 天藤制药株式会社 | 环状乳酸齐聚物的制备方法 |
| US7169814B2 (en) * | 2001-12-11 | 2007-01-30 | The Board Of Trustees Of The Leland Stanford Junior University | Guanidinium transport reagents and conjugates |
| JP2006232909A (ja) * | 2005-02-23 | 2006-09-07 | Tokai Univ | 環状オリゴ乳酸 |
-
2006
- 2006-09-27 EP EP06020286A patent/EP1905454A1/en not_active Withdrawn
-
2007
- 2007-09-26 CN CNA2007800425762A patent/CN101557829A/zh active Pending
- 2007-09-27 EP EP07818525.3A patent/EP2068934B8/en not_active Not-in-force
- 2007-09-27 JP JP2009529613A patent/JP5335677B2/ja not_active Expired - Fee Related
- 2007-09-27 WO PCT/EP2007/008442 patent/WO2008037484A2/en not_active Ceased
- 2007-09-27 CN CN200780043437.1A patent/CN101541346B/zh not_active Expired - Fee Related
- 2007-09-27 AU AU2007302270A patent/AU2007302270B2/en not_active Ceased
- 2007-09-27 BR BRPI0714761A patent/BRPI0714761B8/pt not_active IP Right Cessation
- 2007-09-27 US US12/443,327 patent/US8513188B2/en not_active Expired - Fee Related
- 2007-09-27 CA CA2664568A patent/CA2664568C/en active Active
- 2007-09-27 ES ES07818525.3T patent/ES2691736T3/es active Active
-
2009
- 2009-03-23 IL IL197760A patent/IL197760A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2007302270A1 (en) | 2008-04-03 |
| US20100137188A1 (en) | 2010-06-03 |
| CN101541346B (zh) | 2014-07-02 |
| EP2068934A2 (en) | 2009-06-17 |
| JP2010504934A (ja) | 2010-02-18 |
| CA2664568C (en) | 2015-11-24 |
| BRPI0714761B1 (pt) | 2021-03-23 |
| AU2007302270B2 (en) | 2014-05-29 |
| JP5335677B2 (ja) | 2013-11-06 |
| IL197760A (en) | 2016-10-31 |
| BRPI0714761A2 (pt) | 2013-07-02 |
| CN101557829A (zh) | 2009-10-14 |
| IL197760A0 (en) | 2009-12-24 |
| ES2691736T3 (es) | 2018-11-28 |
| WO2008037484A2 (en) | 2008-04-03 |
| CA2664568A1 (en) | 2008-04-03 |
| US8513188B2 (en) | 2013-08-20 |
| EP2068934B8 (en) | 2018-09-05 |
| WO2008037484A3 (en) | 2008-12-18 |
| CN101541346A (zh) | 2009-09-23 |
| EP2068934B1 (en) | 2018-07-18 |
| EP1905454A1 (en) | 2008-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0714761B8 (pt) | formulações compreendendo compostos cíclicos | |
| RU2009137607A (ru) | Композиции и наборы для лечения гриппа | |
| UY29410A1 (es) | Composiciones farmacéuticas en base a metilamidas del ácido 4-(4-/-3(-4-cloro-3-trifluorometifenil)ureido)fenoxi)piridin-2-carboxílico, procedimiento de preparación y aplicaciones. | |
| BR0111126A (pt) | Derivados de aminoácidos cìclicos úteis como agentes farmacêuticos | |
| BR0208652A (pt) | Composição parenteral reconstituìvel contendo um inibidor de cox-2 | |
| BRPI0514357A (pt) | combinações para o tratamento de doenças que envolvem a proliferação de células | |
| BRPI0409185A (pt) | formulações veterinárias anti-helmìnticas tópicas | |
| BRPI0508579A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI0516825A (pt) | inibição da protease ns3-ns4a do vìrus da hepatite c (vhc) | |
| BRPI0819319B8 (pt) | análogos de aminoglicosídeo antibacteriano | |
| EA200400664A1 (ru) | Фармацевтические композиции, включающие метформин и глибенкламид, применяемые для лечения сахарного диабета типа ii | |
| DK2041133T3 (da) | Derivater af imadazol [1,2-A] pyridine-2-carboxamider, fremstilling deraf og anvendelse deraf i terapeutik | |
| BR112012010333A2 (pt) | peptídeos terapêuticos | |
| CL2004000590A1 (es) | Compuestos derivados de 1,3,4-oxadiazol-3-ona, 1,3,4-tiadiazol-2-ona y de 1,2,4-triazol-3-ona; composicion farmaceutica que los contiene; procedimiento de preparacion y su uso en la preparacion de un medicamento en los que esta relacionado el virus v | |
| BR9808521A (pt) | Moléculas que apresentam um grande número de partes ativas. | |
| AR044200A1 (es) | Composicion de fondaparinux sodico de alta pureza ,un procedimiento de preparacion de esta composicion y composiciones farmaceuticas que la contienen como principio activo | |
| BRPI0513858B8 (pt) | compostos de benziltriazolona como inibidores não-nucleosídeos da transcriptase reversa, seu processo de preparação, seu uso e composição farmacêutica que os compreende | |
| NO20071321L (no) | Anti-inflammatoriske midler | |
| BRPI0417161A (pt) | compostos, composições farmacêuticas, e, uso de um composto | |
| BRPI0315958B8 (pt) | composto, composição farmacêutica, processo para a preparação de um composto, novos intermediários e uso do composto | |
| BRPI0518096A (pt) | composto, composição farmacêutica, uso de um composto para a preparação de um medicamento para o tratamento de uma condição resultante de uma anormalidade na produção de óxido nìtrico, uso de um composto para a preparação de um medicamento para o tratamento da dor em um indivìduo com necessidade do mesmo e uso de um composto para a preparação de um medicamento para o tratamento de inibição da dimerização de inos | |
| WO2007054257A3 (en) | Indene derivatives, their preparation and use as medicaments | |
| EP4335509A3 (en) | Novel glutaminyl cyclase inhibitors and the use thereof in treatment of various diseases | |
| BRPI0414644A (pt) | composto, composições farmacêuticas, e, uso de um composto | |
| BRPI0506496A8 (pt) | Composição farmacêutica com tolerância melhorada no local de injeção compreendendo sulfobutiléter-ss-ciclodextrina e seu uso no tratamento de êmese composição farmacêutica com tolerância melhorada no local de injeção compreendendo sulfobutiléter-ss-ciclodextrina e seu uso no tratamento de êmese composição farmacêutica com tolerância melhorada no local de injeção compreendendo sulfobutiléter-ss-ciclodextrina e seu uso no tratamento de êmese |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B25A | Requested transfer of rights approved |
Owner name: CAPSUGEL BELGIUM (BE) |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 23/03/2021, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 27/09/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 17A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2794 DE 23-07-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |